Primary |
Product Used For Unknown Indication |
57.2% |
Prostate Cancer |
10.8% |
Endometriosis |
9.0% |
In Vitro Fertilisation |
4.2% |
Drug Use For Unknown Indication |
3.8% |
Uterine Leiomyoma |
2.3% |
Infertility |
2.2% |
Precocious Puberty |
1.8% |
Assisted Fertilisation |
1.3% |
Prophylaxis |
1.0% |
Drug Exposure During Pregnancy |
0.9% |
Pain |
0.9% |
Crohn's Disease |
0.8% |
Depression |
0.8% |
Infertility Female |
0.8% |
Excessive Sexual Fantasies |
0.5% |
Hypertension |
0.5% |
Metastases To Bone |
0.5% |
Genital Herpes |
0.4% |
Premenstrual Syndrome |
0.4% |
|
Headache |
16.1% |
Hot Flush |
12.8% |
Weight Increased |
10.0% |
Pain |
6.6% |
Feeling Abnormal |
6.2% |
Weight Decreased |
5.2% |
Unevaluable Event |
4.3% |
Crying |
3.8% |
Nausea |
3.8% |
Death |
3.3% |
Insomnia |
3.3% |
Mood Altered |
3.3% |
Vomiting |
3.3% |
Fatigue |
2.8% |
Mood Swings |
2.8% |
Vision Blurred |
2.8% |
Irritability |
2.4% |
Joint Swelling |
2.4% |
Malaise |
2.4% |
Night Sweats |
2.4% |
|
Secondary |
Prostate Cancer |
33.1% |
Product Used For Unknown Indication |
27.1% |
Osteoporosis |
7.7% |
Endometriosis |
5.2% |
Drug Use For Unknown Indication |
4.0% |
In Vitro Fertilisation |
3.0% |
Infertility |
2.1% |
Blood Cholesterol Increased |
1.9% |
Hypertension |
1.9% |
Breast Cancer Male |
1.8% |
Hypercholesterolaemia |
1.6% |
Ovulation Induction |
1.5% |
Assisted Fertilisation |
1.3% |
Pain |
1.3% |
Anaemia |
1.2% |
Breast Cancer Female |
1.0% |
Erectile Dysfunction |
1.0% |
Infertility Female |
1.0% |
Uterine Leiomyoma |
1.0% |
Amenorrhoea |
0.9% |
|
Weight Decreased |
13.7% |
Vomiting |
8.8% |
Tooth Extraction |
7.8% |
Urinary Tract Infection |
6.9% |
Medication Error |
5.9% |
Stomatitis |
5.9% |
Weight Increased |
5.9% |
Abortion Spontaneous |
4.9% |
Staphylococcal Infection |
4.9% |
Nausea |
3.9% |
Ovarian Hyperstimulation Syndrome |
3.9% |
Pain In Extremity |
3.9% |
Back Pain |
2.9% |
Fatigue |
2.9% |
Hip Fracture |
2.9% |
Malaise |
2.9% |
Pain |
2.9% |
Pyrexia |
2.9% |
Vaginal Haemorrhage |
2.9% |
Vein Disorder |
2.9% |
|
Concomitant |
Prostate Cancer |
26.9% |
Product Used For Unknown Indication |
20.6% |
Prostate Cancer Metastatic |
10.4% |
Metastases To Bone |
6.2% |
Pain |
5.2% |
Drug Use For Unknown Indication |
4.6% |
Hypertension |
4.0% |
Prophylaxis |
3.6% |
Depression |
2.5% |
Asthma |
1.9% |
Back Pain |
1.8% |
Medical Diet |
1.8% |
Nausea |
1.8% |
Hormone Therapy |
1.4% |
Constipation |
1.3% |
Diabetes Mellitus |
1.3% |
Anxiety |
1.2% |
Osteoporosis |
1.2% |
Neoplasm Malignant |
1.1% |
Endometriosis |
1.1% |
|
Weight Decreased |
21.7% |
Vomiting |
8.4% |
Tooth Extraction |
8.3% |
Pulmonary Embolism |
5.8% |
Tooth Fracture |
5.5% |
Prostatic Specific Antigen Increased |
4.8% |
Toothache |
4.8% |
Pyrexia |
4.4% |
Pain |
3.7% |
Death |
3.6% |
Wheezing |
3.6% |
Pneumonia |
3.3% |
Fatigue |
3.0% |
Weight Increased |
3.0% |
Wound Dehiscence |
3.0% |
Osteonecrosis |
2.8% |
Urinary Tract Infection |
2.8% |
Dyspnoea |
2.6% |
White Blood Cell Count Decreased |
2.6% |
Osteonecrosis Of Jaw |
2.5% |
|
Interacting |
Erectile Dysfunction |
68.8% |
Prostate Examination Abnormal |
12.5% |
Prostatomegaly |
12.5% |
Nausea |
6.3% |
|
Vein Disorder |
66.7% |
Hiccups |
16.7% |
Rash |
16.7% |
|